New Insights from PROTECT II Trial Discussed at TCT 2011

October 2, 2015

Hemodynamic Support in High Risk Patients Undergoing Extensive Revascularization: Dr. John Lasala, Dr. Jeff Moses, Dr. Bill O'Neill and Dr. Jeff Popma discuss new data from PROTECT II, the randomized trial on high risk PCI.

To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: